Front Range Biosciences is a biotech company that transfers existing agricultural technology, such as tissue cultures, to the cannabis and coffee industries to create clean stock programs. CFO Nick Hofmeister discusses the company’s recently completed financing round. Front Range raised $10 million and that money will be used to fund the company’s expansion plans at its Boulder, Colorado facilities. While going public is on the company’s radar, Front Range currently has no plans to announce a public offering. The company started generating revenue in 2017 and strategic partnerships with Faith and Family Farms and Fringe Coffee provide access to the California cannabis and coffee markets.

Original article: VIDEO: Front Range Biosciences $10 Million Capital Raise

©2018 Midas Letter. All Rights Reserved.